You are using an outdated browser. For a faster, safer browsing experience, upgrade for free today.

Life & Medical Care

Global Targeted Cancer Drugs Market Analysis 2016-2020 and Forecast 2021-2026

Snapshot

The global Targeted Cancer Drugs market size is estimated at xxx million USD with a CAGR xx% from 2016-2020 and is expected to reach xxx Million USD in 2021 with a CAGR xx% from 2021 to 2026. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Targeted Cancer Drugs by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.

Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
Cancer Growth Blocker Drug
Monoclonal Antibody
Other

Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):
Pfizer
Incyte
Novartis
Eli Lilly
Gilead
Sanofi
Galapagos
AbbVie
Vertex
Teva
Astellas Pharma
Celgene

Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
Hospitals
Academic & Research Institutes
Diagnostic & Reference Laboratories

Region Coverage (Regional Production, Demand & Forecast by Countries etc.):
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
Table of Contents
Table of Contents
1 Industry Overview
1.1 Targeted Cancer Drugs Industry
Figure Targeted Cancer Drugs Industry Chain Structure
1.1.1 Overview
1.1.2 Development of Targeted Cancer Drugs
1.2 Market Segment
1.2.1 Upstream
Table Upstream Segment of Targeted Cancer Drugs
1.2.2 Downstream
Table Application Segment of Targeted Cancer Drugs
Table Global Targeted Cancer Drugs Market 2016-2026, by Application, in USD Million
1.2.3 COVID-19 Impact
1.3 Cost Analysis
2 Industry Environment (PEST Analysis)
2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology
3 Targeted Cancer Drugs Market by Type
3.1 By Type
3.1.1 Cancer Growth Blocker Drug
Table Major Company List of Cancer Growth Blocker Drug
3.1.2 Monoclonal Antibody
Table Major Company List of Monoclonal Antibody
3.1.3 Other
Table Major Company List of Other
3.2 Market Size
Table Global Targeted Cancer Drugs Market 2016-2020, by Type, in USD Million
Figure Global Targeted Cancer Drugs Market Growth 2016-2020, by Type, in USD Million
Table Global Targeted Cancer Drugs Market 2016-2020, by Type, in Volume
Figure Global Targeted Cancer Drugs Market Growth 2016-2020, by Type, in Volume
3.3 Market Forecast
Table Global Targeted Cancer Drugs Market Forecast 2021-2026, by Type, in USD Million
Table Global Targeted Cancer Drugs Market Forecast 2021-2026, by Type, in Volume
4 Major Companies List
4.1 Pfizer (Company Profile, Sales Data etc.)
4.1.1 Pfizer Profile
Table Pfizer Overview List
4.1.2 Pfizer Products & Services
4.1.3 Pfizer Business Operation Conditions
Table Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.2 Incyte (Company Profile, Sales Data etc.)
4.2.1 Incyte Profile
Table Incyte Overview List
4.2.2 Incyte Products & Services
4.2.3 Incyte Business Operation Conditions
Table Business Operation of Incyte (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.3 Novartis (Company Profile, Sales Data etc.)
4.3.1 Novartis Profile
Table Novartis Overview List
4.3.2 Novartis Products & Services
4.3.3 Novartis Business Operation Conditions
Table Business Operation of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.4 Eli Lilly (Company Profile, Sales Data etc.)
4.4.1 Eli Lilly Profile
Table Eli Lilly Overview List
4.4.2 Eli Lilly Products & Services
4.4.3 Eli Lilly Business Operation Conditions
Table Business Operation of Eli Lilly (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.5 Gilead (Company Profile, Sales Data etc.)
4.5.1 Gilead Profile
Table Gilead Overview List
4.5.2 Gilead Products & Services
4.5.3 Gilead Business Operation Conditions
Table Business Operation of Gilead (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.6 Sanofi (Company Profile, Sales Data etc.)
4.6.1 Sanofi Profile
Table Sanofi Overview List
4.6.2 Sanofi Products & Services
4.6.3 Sanofi Business Operation Conditions
Table Business Operation of Sanofi (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.7 Galapagos (Company Profile, Sales Data etc.)
4.7.1 Galapagos Profile
Table Galapagos Overview List
4.7.2 Galapagos Products & Services
4.7.3 Galapagos Business Operation Conditions
Table Business Operation of Galapagos (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.8 AbbVie (Company Profile, Sales Data etc.)
4.8.1 AbbVie Profile
Table AbbVie Overview List
4.8.2 AbbVie Products & Services
4.8.3 AbbVie Business Operation Conditions
Table Business Operation of AbbVie (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.9 Vertex (Company Profile, Sales Data etc.)
4.9.1 Vertex Profile
Table Vertex Overview List
4.9.2 Vertex Products & Services
4.9.3 Vertex Business Operation Conditions
Table Business Operation of Vertex (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.10 Teva (Company Profile, Sales Data etc.)
4.10.1 Teva Profile
Table Teva Overview List
4.10.2 Teva Products & Services
4.10.3 Teva Business Operation Conditions
Table Business Operation of Teva (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.11 Astellas Pharma (Company Profile, Sales Data etc.)
4.11.1 Astellas Pharma Profile
Table Astellas Pharma Overview List
4.11.2 Astellas Pharma Products & Services
4.11.3 Astellas Pharma Business Operation Conditions
Table Business Operation of Astellas Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.12 Celgene (Company Profile, Sales Data etc.)
4.12.1 Celgene Profile
Table Celgene Overview List
4.12.2 Celgene Products & Services
4.12.3 Celgene Business Operation Conditions
Table Business Operation of Celgene (Sales Revenue, Cost, Gross Margin)
5 Market Competition
5.1 Company Competition
Table Global Targeted Cancer Drugs Sales Revenue 2016-2020, by Company, in USD Million
Table Global Targeted Cancer Drugs Sales Revenue Share 2016-2020, by Company, in USD Million
Figure Global Targeted Cancer Drugs Sales Revenue Share in 2020, by Company, in USD Million
Table Global Targeted Cancer Drugs Sales Volume 2016-2020, by Company, in Volume
Table Global Targeted Cancer Drugs Sales Volume Share 2016-2020, by Company, in Volume
Figure Global Targeted Cancer Drugs Sales Volume Share in 2020, by Company, in Volume
5.2 Regional Market by Company
Figure North America Targeted Cancer Drugs Market Concentration, in 2020
Figure Europe Targeted Cancer Drugs Market Market Concentration, in 2020
Figure Asia-Pacific Targeted Cancer Drugs MMarket Concentration, in 2020
Figure South America Targeted Cancer Drugs Market Concentration, in 2020
Figure Middle East & Africa Targeted Cancer Drugs Market Concentration, in 2020
6 Demand by End Market
6.1 Demand Situation
6.1.1 Demand in Hospitals
Figure Targeted Cancer Drugs Demand in Hospitals, 2016-2020, in USD Million
Figure Targeted Cancer Drugs Demand in Hospitals, 2016-2020, in Volume
6.1.2 Demand in Academic & Research Institutes
Figure Targeted Cancer Drugs Demand in Academic & Research Institutes, 2016-2020, in USD Million
Figure Targeted Cancer Drugs Demand in Academic & Research Institutes, 2016-2020, in Volume
6.1.3 Demand in Diagnostic & Reference Laboratories
Figure Targeted Cancer Drugs Demand in Diagnostic & Reference Laboratories, 2016-2020, in USD Million
Figure Targeted Cancer Drugs Demand in Diagnostic & Reference Laboratories, 2016-2020, in Volume
6.2 Regional Demand Comparison
Table Regional Demand Comparison List
Table Major Application in Different Regions
6.3 Demand Forecast
Table Targeted Cancer Drugs Demand Forecast 2021-2026, by Application, in USD Million
Figure Targeted Cancer Drugs Market Growth 2021-2026, by Application, in USD Million
Figure Targeted Cancer Drugs Market Share in 2026, by Application, in USD Million
Table Targeted Cancer Drugs Demand Forecast 2021-2026, by Application, in Volume
Table Targeted Cancer Drugs Market Growth 2021-2026, by Application, in Volume
Table Targeted Cancer Drugs Market Share in 2026, by Application, in Volume
6.4 Impact of the COVID-19 on the Demand
7 Region Operation
7.1 Regional Production
Table Targeted Cancer Drugs Production 2016-2020, by Region, in USD Million
Table Targeted Cancer Drugs Production 2016-2020, by Region, in Volume
7.2 Regional Market
Table Global Targeted Cancer Drugs Market 2016-2020, by Region, in USD Million
Table Global Targeted Cancer Drugs Market Share 2016-2020, by Region, in USD Million
Table Global Targeted Cancer Drugs Market 2016-2020, by Region, in Volume
Table Global Targeted Cancer Drugs Market Share 2016-2020, by Region, in Volume
7.3 by Region
7.3.1 North America
7.3.1.1 Overview
Figure North America Targeted Cancer Drugs Market Size and Growth 2016-2020, in USD Million
Figure North America Targeted Cancer Drugs Market Size and Growth 2016-2020, in Volume
7.3.1.2 by Country (U.S., Canada, Mexico)
Table North America Targeted Cancer Drugs Market Size 2016-2020, by Country, in USD Million
Table North America Targeted Cancer Drugs Market Size 2016-2020, by Country, in Volume
7.3.2 Europe
7.3.2.1 Overview
Figure Europe Targeted Cancer Drugs Market Size and Growth 2016-2020, in USD Million
Figure Europe Targeted Cancer Drugs Market Size and Growth 2016-2020, in Volume
7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
Table Europe Targeted Cancer Drugs Market Size 2016-2020, by Country, in USD Million
Table Europe Targeted Cancer Drugs Market Size 2016-2020, by Country, in Volume
7.3.3 Asia-Pacific
7.3.3.1 Overview
Figure Asia-Pacific Targeted Cancer Drugs Market Size and Growth 2016-2020, in USD Million
Figure Asia-Pacific Targeted Cancer Drugs Market Size and Growth 2016-2020, in Volume
7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
Table Asia-Pacific Targeted Cancer Drugs Market Size 2016-2020, by Country, in USD Million
Table Asia-Pacific Targeted Cancer Drugs Market Size 2016-2020, by Country, in Volume
7.3.4 South America
7.3.4.1 Overview
Figure South America Targeted Cancer Drugs Market Size and Growth 2016-2020, in USD Million
Figure South America Targeted Cancer Drugs Market Size and Growth 2016-2020, in Volume
7.3.4.2 by Country (Brazil, Argentina etc.)
Table South America Targeted Cancer Drugs Market Size 2016-2020, by Country, in USD Million
Table South America Targeted Cancer Drugs Market Size 2016-2020, by Country, in Volume
7.3.5 Middle East & Africa
7.3.5.1 Overview
Figure Middle East & Africa Targeted Cancer Drugs Market Size and Growth 2016-2020, in USD Million
Figure Middle East & Africa Targeted Cancer Drugs Market Size and Growth 2016-2020, in Volume
7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
Table Middle East & Africa Targeted Cancer Drugs Market Size 2016-2020, by Country, in USD Million
Table Middle East & Africa Targeted Cancer Drugs Market Size 2016-2020, by Country, in Volume
7.4 Regional Import & Export
7.5 Regional Forecast
Table Targeted Cancer Drugs Market Forecast 2021-2026, by Region, in USD Million
Table Targeted Cancer Drugs Market Forecast 2021-2026, by Region, in Volume
8 Marketing & Price
8.1 Price and Margin
8.1.1 Price Trends
8.1.2 Factors of Price Change
Table Price Factors List
8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel
Figure Marketing Channels Overview
9 Research Conclusion
  • FORMAT: PDF
  • PUBLISHED DATE: May, 2021
  • NO OF PAGES: 81